Axcan, Cellerix in Cx401 deal

Cellerix (Madrid, Spain) granted gastrointestinal company Axcan (TSX:AXP; AXCA) exclusive North American rights to Cx401, which is in Phase III testing in Europe to treat perianal fistulas. AXP plans ...